| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | LAMA3 LAMA5 LAMB3 PAPLN LAMC2 MATN4 CCN1 LTBP4 MUC5AC TNXB FBN3 | 1.51e-09 | 188 | 95 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | integrin binding | 1.53e-07 | 175 | 95 | 9 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.30e-06 | 73 | 95 | 6 | GO:0050840 | |
| GeneOntologyMolecularFunction | frizzled binding | 4.68e-05 | 42 | 95 | 4 | GO:0005109 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | RARS1 LAMA5 ITGA6 ITGA9 ITGB5 ITGB6 CCN1 EGFR LTBP4 TNXB NOTCH3 | 1.29e-04 | 599 | 95 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.93e-04 | 268 | 95 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | structural molecule activity | LAMA3 LAMA5 LAMB3 PAPLN LAMC2 MATN4 ACTL7B CCN1 LTBP4 MUC5AC TNXB FBN3 | 1.05e-03 | 891 | 95 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 1.29e-03 | 554 | 95 | 9 | GO:0030546 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | TCF15 LAMB3 PAPLN MATN4 BMP1 CCN1 ADAMTS9 ADAMTS15 LTBP4 TNXB | 8.54e-06 | 377 | 94 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | TCF15 LAMB3 PAPLN MATN4 BMP1 CCN1 ADAMTS9 ADAMTS15 LTBP4 TNXB | 8.74e-06 | 378 | 94 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | TCF15 LAMB3 PAPLN MATN4 BMP1 CCN1 ADAMTS9 ADAMTS15 LTBP4 TNXB | 8.94e-06 | 379 | 94 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | positive regulation of timing of anagen | 2.05e-05 | 2 | 94 | 2 | GO:0051885 | |
| GeneOntologyBiologicalProcess | cornea development in camera-type eye | 4.92e-05 | 16 | 94 | 3 | GO:0061303 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TCF15 WNT5A WNT6 WNT10B WNT9A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 CHST11 ITGB6 BMP1 CCN1 EGFR ADAMTS9 CSMD1 | 5.38e-05 | 1269 | 94 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | tube development | FOXM1 CDKN1A STAB2 THSD7A WNT5A WNT6 LAMA5 ITGB6 LHX2 CCN1 EGFR ADAMTS9 CBFA2T2 CHRD GPSM2 CSMD1 NOTCH3 TP73 | 5.46e-05 | 1402 | 94 | 18 | GO:0035295 |
| GeneOntologyBiologicalProcess | digestive tract development | 6.93e-05 | 152 | 94 | 6 | GO:0048565 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.06e-04 | 410 | 94 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | skeletal system development | TCF15 MCPH1 WNT5A WNT10B WNT9A LAMA5 CHST11 ITGB6 BMP1 CCN1 CHRD | 1.11e-04 | 615 | 94 | 11 | GO:0001501 |
| GeneOntologyBiologicalProcess | digestive system development | 1.16e-04 | 167 | 94 | 6 | GO:0055123 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.57e-04 | 338 | 94 | 8 | GO:0045165 | |
| GeneOntologyBiologicalProcess | positive regulation of hair follicle maturation | 2.04e-04 | 5 | 94 | 2 | GO:0048818 | |
| GeneOntologyBiologicalProcess | cGMP catabolic process | 2.04e-04 | 5 | 94 | 2 | GO:0046069 | |
| GeneOntologyBiologicalProcess | luteinizing hormone signaling pathway involved in ovarian follicle development | 2.04e-04 | 5 | 94 | 2 | GO:0035471 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | CDKN1A TCF15 WNT5A WNT9A CHST11 UPF3A LRP1B LHX2 KMT2D SEC24C CCN1 EGFR CHRD | 2.32e-04 | 906 | 94 | 13 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development | CDKN1A TCF15 WNT5A WNT6 WNT9A LAMA3 LAMA5 CHST11 UPF3A LRP1B LHX2 KMT2D SEC24C CCN1 EGFR CHRD EN2 | 2.43e-04 | 1437 | 94 | 17 | GO:0009790 |
| GeneOntologyBiologicalProcess | hair follicle development | 2.50e-04 | 123 | 94 | 5 | GO:0001942 | |
| GeneOntologyBiologicalProcess | epidermis development | 2.55e-04 | 461 | 94 | 9 | GO:0008544 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response | 2.55e-04 | 193 | 94 | 6 | GO:0050729 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.59e-04 | 124 | 94 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | molting cycle process | 2.79e-04 | 126 | 94 | 5 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 2.79e-04 | 126 | 94 | 5 | GO:0022405 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | CDKN1A TCF15 WNT5A WNT9A CHST11 UPF3A LRP1B LHX2 KMT2D SEC24C CCN1 EGFR CHRD | 2.96e-04 | 929 | 94 | 13 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of timing of anagen | 3.05e-04 | 6 | 94 | 2 | GO:0051884 | |
| GeneOntologyBiologicalProcess | skin development | 3.05e-04 | 373 | 94 | 8 | GO:0043588 | |
| GeneOntologyBiologicalProcess | post-anal tail morphogenesis | 3.07e-04 | 29 | 94 | 3 | GO:0036342 | |
| GeneOntologyBiologicalProcess | epithelium development | CDKN1A PDE2A TCF15 WNT5A WNT6 WNT10B WNT9A LAMA5 ITGB5 LHX2 CCN1 EGFR CBFA2T2 CHRD GPSM2 CSMD1 TP73 | 3.14e-04 | 1469 | 94 | 17 | GO:0060429 |
| GeneOntologyBiologicalProcess | axon guidance | 3.28e-04 | 285 | 94 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 3.35e-04 | 286 | 94 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cellular response to retinoic acid | 3.46e-04 | 73 | 94 | 4 | GO:0071300 | |
| GeneOntologyBiologicalProcess | luteinizing hormone signaling pathway | 4.25e-04 | 7 | 94 | 2 | GO:0042700 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase C activity | 4.25e-04 | 7 | 94 | 2 | GO:1900020 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase C activity | 4.25e-04 | 7 | 94 | 2 | GO:1900019 | |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 5.15e-04 | 81 | 94 | 4 | GO:0061035 | |
| GeneOntologyBiologicalProcess | blastoderm segmentation | 5.40e-04 | 35 | 94 | 3 | GO:0007350 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | FOXM1 STAB2 THSD7A WNT5A WNT6 LAMA5 LHX2 CCN1 EGFR ADAMTS9 CHRD CSMD1 NOTCH3 TP73 | 5.57e-04 | 1125 | 94 | 14 | GO:0035239 |
| GeneOntologyBiologicalProcess | positive regulation of cartilage development | 5.87e-04 | 36 | 94 | 3 | GO:0061036 | |
| GeneOntologyBiologicalProcess | molting cycle | 6.21e-04 | 150 | 94 | 5 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 6.21e-04 | 150 | 94 | 5 | GO:0042633 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental pigmentation | 7.25e-04 | 9 | 94 | 2 | GO:0048087 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 7.99e-04 | 91 | 94 | 4 | GO:0033627 | |
| GeneOntologyBiologicalProcess | regulation of hair follicle maturation | 9.03e-04 | 10 | 94 | 2 | GO:0048819 | |
| GeneOntologyBiologicalProcess | positive regulation of hematopoietic stem cell proliferation | 9.03e-04 | 10 | 94 | 2 | GO:1902035 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 9.72e-04 | 445 | 94 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 9.80e-04 | 166 | 94 | 5 | GO:0098773 | |
| GeneOntologyCellularComponent | extracellular matrix | ZAN WNT5A CTSC WNT6 LAMA3 LAMA5 ITGA6 LAMB3 PAPLN LAMC2 MATN4 BMP1 CCN1 ADAMTS9 FCN1 ADAMTS15 NGLY1 LTBP4 MUC5AC TNXB FBN3 | 1.09e-12 | 656 | 94 | 21 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ZAN WNT5A CTSC WNT6 LAMA3 LAMA5 ITGA6 LAMB3 PAPLN LAMC2 MATN4 BMP1 CCN1 ADAMTS9 FCN1 ADAMTS15 NGLY1 LTBP4 MUC5AC TNXB FBN3 | 1.16e-12 | 658 | 94 | 21 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | WNT5A CTSC LAMA3 LAMA5 ITGA6 LAMB3 PAPLN LAMC2 MATN4 BMP1 CCN1 ADAMTS9 FCN1 ADAMTS15 NGLY1 LTBP4 TNXB | 1.99e-10 | 530 | 94 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | laminin-5 complex | 3.83e-10 | 4 | 94 | 4 | GO:0005610 | |
| GeneOntologyCellularComponent | laminin complex | 7.89e-08 | 10 | 94 | 4 | GO:0043256 | |
| GeneOntologyCellularComponent | pituitary gonadotropin complex | 4.85e-06 | 8 | 94 | 3 | GO:0061696 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 6.82e-06 | 59 | 94 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | integrin complex | 1.25e-05 | 32 | 94 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | basement membrane | 1.87e-05 | 122 | 94 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | cell surface | STAB2 WNT5A WNT6 ITGA6 ITGA9 ITGB5 ITGB6 EGFR ADAMTS9 FCN1 SCARA5 ADAMTS15 CHRD NOTCH3 | 4.31e-04 | 1111 | 94 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | hemidesmosome | 1.07e-03 | 11 | 94 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | microfibril | 1.51e-03 | 13 | 94 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 2.71e-03 | 212 | 94 | 5 | GO:0030666 | |
| HumanPheno | Hypoplastic dermoepidermal hemidesmosomes | 5.71e-08 | 7 | 34 | 4 | HP:0020117 | |
| HumanPheno | Abdominal organ duplication | 2.47e-07 | 69 | 34 | 7 | HP:0005217 | |
| HumanPheno | Renal duplication | 2.47e-07 | 69 | 34 | 7 | HP:0000075 | |
| HumanPheno | Abnormal dermatological laboratory findings | 3.38e-07 | 10 | 34 | 4 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 3.38e-07 | 10 | 34 | 4 | HP:0003341 | |
| HumanPheno | Duplicated collecting system | 3.79e-07 | 24 | 34 | 5 | HP:0000081 | |
| HumanPheno | Subepidermal blistering | 5.28e-07 | 11 | 34 | 4 | HP:0033804 | |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 5.28e-07 | 11 | 34 | 4 | HP:0032449 | |
| HumanPheno | Abnormal dermoepidermal junction morphology | 7.89e-07 | 12 | 34 | 4 | HP:0031538 | |
| HumanPheno | Blistering by histological location | 1.13e-06 | 13 | 34 | 4 | HP:0033801 | |
| HumanPheno | Abnormal renal collecting system morphology | 1.23e-06 | 30 | 34 | 5 | HP:0004742 | |
| HumanPheno | Oral mucosal blisters | 1.58e-06 | 14 | 34 | 4 | HP:0200097 | |
| HumanPheno | Hoarse cry | 2.14e-06 | 15 | 34 | 4 | HP:0001615 | |
| HumanPheno | Renal tubular epithelial necrosis | 2.69e-06 | 5 | 34 | 3 | HP:0008682 | |
| HumanPheno | Renal necrosis | 2.69e-06 | 5 | 34 | 3 | HP:0032618 | |
| HumanPheno | Pyoderma | 2.69e-06 | 5 | 34 | 3 | HP:0000999 | |
| HumanPheno | Aplasia/Hypoplasia of the bladder | 2.85e-06 | 16 | 34 | 4 | HP:0010476 | |
| HumanPheno | Scarring | 3.62e-06 | 102 | 34 | 7 | HP:0100699 | |
| HumanPheno | Atrophic scars | 3.65e-06 | 37 | 34 | 5 | HP:0001075 | |
| HumanPheno | Urethral stricture | 3.70e-06 | 17 | 34 | 4 | HP:0012227 | |
| HumanPheno | Ureteral duplication | 4.15e-06 | 67 | 34 | 6 | HP:0000073 | |
| HumanPheno | Ureteral obstruction | 4.78e-06 | 39 | 34 | 5 | HP:0006000 | |
| HumanPheno | Nail dystrophy | 5.96e-06 | 156 | 34 | 8 | HP:0008404 | |
| HumanPheno | Recurrent bacterial skin infections | 6.96e-06 | 42 | 34 | 5 | HP:0005406 | |
| HumanPheno | Atypical scarring of skin | 7.46e-06 | 74 | 34 | 6 | HP:0000987 | |
| HumanPheno | Congenital localized absence of skin | 2.22e-05 | 9 | 34 | 3 | HP:0007383 | |
| HumanPheno | Mitten deformity | 2.22e-05 | 9 | 34 | 3 | HP:0004057 | |
| HumanPheno | Blistering by anatomical location | 2.23e-05 | 26 | 34 | 4 | HP:0033800 | |
| HumanPheno | Ureterocele | 3.49e-05 | 29 | 34 | 4 | HP:0000070 | |
| HumanPheno | Sparse body hair | 4.81e-05 | 62 | 34 | 5 | HP:0002231 | |
| HumanPheno | Enamel hypoplasia | 5.30e-05 | 104 | 34 | 6 | HP:0006297 | |
| HumanPheno | Esophageal stenosis | 5.91e-05 | 33 | 34 | 4 | HP:0010450 | |
| HumanPheno | Urethral obstruction | 8.08e-05 | 69 | 34 | 5 | HP:0000796 | |
| HumanPheno | Abnormal ureter morphology | 9.85e-05 | 169 | 34 | 7 | HP:0025633 | |
| HumanPheno | Abnormal odontoid tissue morphology | 1.27e-04 | 238 | 34 | 8 | HP:3000050 | |
| HumanPheno | Aplasia cutis congenita | 1.41e-04 | 41 | 34 | 4 | HP:0001057 | |
| HumanPheno | Laryngeal stenosis | 1.43e-04 | 16 | 34 | 3 | HP:0001602 | |
| HumanPheno | Scarring alopecia of scalp | 1.43e-04 | 16 | 34 | 3 | HP:0004552 | |
| HumanPheno | Paronychia | 1.43e-04 | 16 | 34 | 3 | HP:0001818 | |
| HumanPheno | Hypoplasia of teeth | 1.55e-04 | 126 | 34 | 6 | HP:0000685 | |
| HumanPheno | Abnormal ureter physiology | 1.56e-04 | 245 | 34 | 8 | HP:0025634 | |
| HumanPheno | Milia | 1.73e-04 | 17 | 34 | 3 | HP:0001056 | |
| HumanPheno | Dysuria | 2.07e-04 | 18 | 34 | 3 | HP:0100518 | |
| HumanPheno | Lagophthalmos | 2.45e-04 | 19 | 34 | 3 | HP:0030001 | |
| HumanPheno | Nail dysplasia | 2.61e-04 | 264 | 34 | 8 | HP:0002164 | |
| HumanPheno | Hydronephrosis | 2.61e-04 | 264 | 34 | 8 | HP:0000126 | |
| HumanPheno | Esophageal stricture | 2.87e-04 | 20 | 34 | 3 | HP:0002043 | |
| HumanPheno | Unexplained fevers | 2.87e-04 | 20 | 34 | 3 | HP:0001955 | |
| HumanPheno | Abnormality of the dentition | WNT5A CTSC WNT10B APC2 LAMA3 ITGA6 LAMB3 LAMC2 HUWE1 ITGB6 BMP1 SMG8 KMT2D SEC24C ADAMTS15 NOTCH3 | 3.79e-04 | 1030 | 34 | 16 | HP:0000164 |
| HumanPheno | Abnormality of the periungual region | 3.84e-04 | 22 | 34 | 3 | HP:0100803 | |
| HumanPheno | Abnormality of the bladder | MCPH1 APC2 LAMA3 ITGA6 LAMB3 LAMC2 BMP1 KMT2D SEC24C LTBP4 TNXB NOTCH3 | 4.16e-04 | 621 | 34 | 12 | HP:0000014 |
| HumanPheno | Tooth agenesis | 4.54e-04 | 363 | 34 | 9 | HP:0009804 | |
| HumanPheno | Abnormality of the lower urinary tract | MCPH1 WNT5A APC2 LAMA3 ITGA6 LAMB3 LAMC2 HUWE1 BMP1 SMG8 KMT2D SEC24C LTBP4 TNXB NOTCH3 | 4.68e-04 | 937 | 34 | 15 | HP:0010936 |
| HumanPheno | Dilatation of the renal pelvis | 4.95e-04 | 290 | 34 | 8 | HP:0010946 | |
| HumanPheno | Abnormality of dental structure | 5.03e-04 | 368 | 34 | 9 | HP:0011061 | |
| HumanPheno | Urethral stenosis | 5.09e-04 | 57 | 34 | 4 | HP:0008661 | |
| HumanPheno | Abnormal dental enamel morphology | 5.19e-04 | 221 | 34 | 7 | HP:0000682 | |
| HumanPheno | Abnormal thymus morphology | 5.44e-04 | 58 | 34 | 4 | HP:0000777 | |
| HumanPheno | Recurrent skin infections | 5.48e-04 | 159 | 34 | 6 | HP:0001581 | |
| HumanPheno | Abnormal renal pelvis morphology | 6.22e-04 | 300 | 34 | 8 | HP:0010944 | |
| HumanPheno | Dehydration | 6.38e-04 | 107 | 34 | 5 | HP:0001944 | |
| HumanPheno | Dermal atrophy | 6.38e-04 | 107 | 34 | 5 | HP:0004334 | |
| HumanPheno | Abnormality of the pylorus | 6.38e-04 | 107 | 34 | 5 | HP:0004400 | |
| HumanPheno | Tapered distal phalanges of finger | 6.38e-04 | 6 | 34 | 2 | HP:0009884 | |
| HumanPheno | Abnormality of the urethra | 6.39e-04 | 465 | 34 | 10 | HP:0000795 | |
| HumanPheno | Abnormality of the ureter | 6.74e-04 | 383 | 34 | 9 | HP:0000069 | |
| HumanPheno | Abnormality of skin pigmentation | CDKN1A CTSC APC2 LAMA3 LAMB3 LAMC2 SMG8 KMT2D SEC24C HPS4 NOTCH3 | 6.98e-04 | 561 | 34 | 11 | HP:0001000 |
| HumanPheno | Urinary retention | 7.12e-04 | 27 | 34 | 3 | HP:0000016 | |
| HumanPheno | Abnormal tendency to infections of the skin | 7.58e-04 | 169 | 34 | 6 | HP:0002727 | |
| HumanPheno | Skin erosion | 7.94e-04 | 28 | 34 | 3 | HP:0200041 | |
| HumanPheno | Oligodontia | 8.40e-04 | 65 | 34 | 4 | HP:0000677 | |
| HumanPheno | Onychogryposis | 8.82e-04 | 29 | 34 | 3 | HP:0001805 | |
| HumanPheno | Functional abnormality of the bladder | MCPH1 APC2 LAMA3 ITGA6 LAMB3 LAMC2 BMP1 KMT2D SEC24C TNXB NOTCH3 | 1.07e-03 | 590 | 34 | 11 | HP:0000009 |
| HumanPheno | Abnormality of external features of the abdomen | 1.08e-03 | 326 | 34 | 8 | HP:0001462 | |
| HumanPheno | Squamous cell carcinoma | 1.17e-03 | 71 | 34 | 4 | HP:0002860 | |
| HumanPheno | Amelogenesis imperfecta | 1.29e-03 | 33 | 34 | 3 | HP:0000705 | |
| HumanPheno | Abnormal number of teeth | 1.34e-03 | 421 | 34 | 9 | HP:0006483 | |
| HumanPheno | Abnormal nail morphology | 1.44e-03 | 516 | 34 | 10 | HP:0001597 | |
| HumanPheno | Abnormality of the scalp hair | 1.63e-03 | 433 | 34 | 9 | HP:0100037 | |
| MousePheno | abnormal outer ear morphology | 3.34e-06 | 119 | 75 | 7 | MP:0002177 | |
| MousePheno | abnormal head morphology | CDKN1A TCF15 MCPH1 WNT5A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 CHST11 HUWE1 ITGB6 LHX2 KMT2D EGFR HPS4 CHRD TP73 DNMT3B | 4.81e-06 | 1120 | 75 | 19 | MP:0000432 |
| MousePheno | blistering | 7.49e-06 | 24 | 75 | 4 | MP:0001208 | |
| MousePheno | abnormal viscerocranium morphology | WNT5A WNT9A LAMA3 LAMA5 LAMB3 LAMC2 CHST11 ITGB6 BMP1 KMT2D EGFR CHRD DNMT3B | 1.42e-05 | 593 | 75 | 13 | MP:0005274 |
| MousePheno | short facial bone | 1.95e-05 | 104 | 75 | 6 | MP:0030384 | |
| MousePheno | abnormal cranium morphology | TCF15 WNT5A WNT9A LAMA3 LAMA5 LAMB3 LAMC2 CHST11 ITGB6 BMP1 KMT2D EGFR CHRD TP73 DNMT3B | 2.22e-05 | 813 | 75 | 15 | MP:0000438 |
| MousePheno | abnormal craniofacial bone morphology | TCF15 WNT5A WNT9A LAMA3 LAMA5 LAMB3 LAMC2 CHST11 ITGB6 BMP1 KMT2D EGFR CHRD TP73 DNMT3B | 2.72e-05 | 827 | 75 | 15 | MP:0002116 |
| MousePheno | abnormal epidermal-dermal junction morphology | 3.15e-05 | 12 | 75 | 3 | MP:0011159 | |
| MousePheno | decreased hair follicle number | 6.66e-05 | 41 | 75 | 4 | MP:0000379 | |
| MousePheno | abnormal facial morphology | CDKN1A WNT5A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 CHST11 ITGB6 LHX2 KMT2D EGFR CHRD TP73 DNMT3B | 8.14e-05 | 910 | 75 | 15 | MP:0003743 |
| MousePheno | abnormal craniofacial morphology | CDKN1A TCF15 WNT5A WNT9A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 CHST11 ITGB6 BMP1 LHX2 KMT2D EGFR HPS4 CHRD TP73 DNMT3B | 8.34e-05 | 1372 | 75 | 19 | MP:0000428 |
| MousePheno | craniofacial phenotype | CDKN1A TCF15 WNT5A WNT9A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 CHST11 ITGB6 BMP1 LHX2 KMT2D EGFR HPS4 CHRD TP73 DNMT3B | 8.34e-05 | 1372 | 75 | 19 | MP:0005382 |
| MousePheno | hyoid bone hypoplasia | 8.49e-05 | 3 | 75 | 2 | MP:0009899 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | FOXM1 PDE2A TCF15 WNT5A WNT9A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 CHST11 ITGA9 LHX2 CCN1 EGFR CHRD NGLY1 DNMT3B | 9.90e-05 | 1269 | 75 | 18 | MP:0011111 |
| MousePheno | abnormal artery morphology | 1.15e-04 | 440 | 75 | 10 | MP:0002191 | |
| MousePheno | decreased hyoid bone size | 1.69e-04 | 4 | 75 | 2 | MP:0009912 | |
| MousePheno | abnormal external male genitalia morphology | 1.83e-04 | 53 | 75 | 4 | MP:0009199 | |
| MousePheno | abnormal external female genitalia morphology | 1.84e-04 | 21 | 75 | 3 | MP:0003126 | |
| MousePheno | abnormal axial skeleton morphology | TCF15 WNT5A WNT9A LAMA3 LAMA5 LAMB3 LAMC2 CHST11 ITGB6 BMP1 KMT2D EGFR CHRD PDE5A CSMD1 LTBP4 NOTCH3 TP73 DNMT3B | 1.87e-04 | 1458 | 75 | 19 | MP:0002114 |
| MousePheno | abnormal mouth morphology | CDKN1A WNT5A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 CHST11 ITGB6 EGFR CHRD DNMT3B | 2.17e-04 | 670 | 75 | 12 | MP:0000452 |
| MousePheno | abnormal digestive system morphology | CDKN1A WNT5A WNT10B LAMA3 LAMA5 LAMB3 LAMC2 CHST11 NLRP6 BMP1 EGFR CBFA2T2 CHRD LTBP4 MUC5AC TP73 DNMT3B | 2.27e-04 | 1233 | 75 | 17 | MP:0000462 |
| MousePheno | abnormal respiratory system morphology | FOXM1 CDKN1A WNT5A LAMA3 LAMA5 LAMB3 CHST11 ITGA9 ITGB6 EGFR CHRD LRRC56 LTBP4 TP73 DNMT3B | 3.09e-04 | 1027 | 75 | 15 | MP:0002132 |
| MousePheno | abnormal respiration | FOXM1 TCF15 WNT5A LAMA3 LAMC2 CHST11 ITGA9 ITGB6 PASK EGFR LTBP4 | 3.25e-04 | 598 | 75 | 11 | MP:0001943 |
| MousePheno | short mandible | 3.81e-04 | 64 | 75 | 4 | MP:0000088 | |
| MousePheno | small vulva | 4.20e-04 | 6 | 75 | 2 | MP:0003527 | |
| MousePheno | abnormal oropharynx morphology | 4.20e-04 | 6 | 75 | 2 | MP:0002252 | |
| MousePheno | small trachea | 4.20e-04 | 6 | 75 | 2 | MP:0004549 | |
| MousePheno | abnormal intestinal goblet cell morphology | 4.28e-04 | 66 | 75 | 4 | MP:0003449 | |
| MousePheno | abnormal ear position | 4.41e-04 | 28 | 75 | 3 | MP:0000023 | |
| MousePheno | abnormal jaw morphology | 5.10e-04 | 530 | 75 | 10 | MP:0000454 | |
| MousePheno | small bulbourethral gland | 5.86e-04 | 7 | 75 | 2 | MP:0013737 | |
| MousePheno | abnormal intestine morphology | WNT5A WNT10B LAMA5 NLRP6 BMP1 EGFR CBFA2T2 LTBP4 MUC5AC TP73 | 6.42e-04 | 546 | 75 | 10 | MP:0000477 |
| MousePheno | small external male genitalia | 7.79e-04 | 8 | 75 | 2 | MP:0009202 | |
| MousePheno | digestive/alimentary phenotype | CDKN1A WNT5A WNT10B LAMA3 LAMA5 LAMB3 LAMC2 CHST11 NLRP6 BMP1 EGFR CBFA2T2 CHRD EN2 LTBP4 MUC5AC TP73 DNMT3B | 7.81e-04 | 1500 | 75 | 18 | MP:0005381 |
| MousePheno | respiratory distress | 7.83e-04 | 204 | 75 | 6 | MP:0001954 | |
| MousePheno | abnormal respiratory mechanics | 7.83e-04 | 135 | 75 | 5 | MP:0002314 | |
| MousePheno | abnormal basioccipital bone morphology | 7.88e-04 | 34 | 75 | 3 | MP:0000079 | |
| MousePheno | abnormal cortical plate morphology | 8.58e-04 | 35 | 75 | 3 | MP:0008439 | |
| MousePheno | abnormal respiratory system physiology | FOXM1 TCF15 WNT5A LAMA3 LAMC2 CHST11 ITGA9 ITGB6 PASK EGFR SCARA5 LTBP4 TP73 | 8.85e-04 | 897 | 75 | 13 | MP:0002133 |
| MousePheno | abnormal ear morphology | 8.91e-04 | 470 | 75 | 9 | MP:0002102 | |
| MousePheno | abnormal head size | 9.23e-04 | 140 | 75 | 5 | MP:0011496 | |
| MousePheno | hearing/vestibular/ear phenotype | TCF15 MCPH1 WNT5A LAMA5 LAMC2 KMT2D EGFR HPS4 ADAMTS15 CHRD GPSM2 NOTCH3 TP73 | 9.60e-04 | 905 | 75 | 13 | MP:0005377 |
| Domain | EGF_1 | ATRN STAB2 ZAN LAMA3 LAMA5 LAMB3 LAMC2 MATN4 LRP1B ITGB5 ITGB6 BMP1 DLK2 LTBP4 TNXB FBN3 NOTCH3 | 9.62e-15 | 255 | 94 | 17 | PS00022 |
| Domain | EGF-like_CS | ATRN STAB2 ZAN LAMA3 LAMA5 LAMB3 LAMC2 MATN4 LRP1B ITGB5 ITGB6 BMP1 DLK2 LTBP4 TNXB FBN3 NOTCH3 | 1.41e-14 | 261 | 94 | 17 | IPR013032 |
| Domain | EGF_2 | ATRN STAB2 ZAN LAMA3 LAMA5 LAMB3 LAMC2 MATN4 LRP1B ITGB5 ITGB6 BMP1 DLK2 LTBP4 TNXB FBN3 NOTCH3 | 1.82e-14 | 265 | 94 | 17 | PS01186 |
| Domain | Growth_fac_rcpt_ | ATRN STAB2 LAMA3 LAMA5 LAMC2 MATN4 LRP1B BMP1 CCN1 EGFR LTBP4 TNXB FBN3 NOTCH3 | 4.37e-14 | 156 | 94 | 14 | IPR009030 |
| Domain | EGF | ATRN STAB2 ZAN LAMA3 LAMA5 LAMC2 MATN4 LRP1B ITGB5 BMP1 DLK2 LTBP4 TNXB FBN3 NOTCH3 | 7.72e-13 | 235 | 94 | 15 | SM00181 |
| Domain | EGF-like_dom | ATRN STAB2 ZAN LAMA3 LAMA5 LAMC2 MATN4 LRP1B BMP1 DLK2 LTBP4 TNXB FBN3 NOTCH3 | 2.63e-11 | 249 | 94 | 14 | IPR000742 |
| Domain | EGF | 3.64e-11 | 126 | 94 | 11 | PF00008 | |
| Domain | EGF_extracell | 6.28e-10 | 60 | 94 | 8 | IPR013111 | |
| Domain | EGF_2 | 6.28e-10 | 60 | 94 | 8 | PF07974 | |
| Domain | EGF_LAM_2 | 7.45e-09 | 30 | 94 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 7.45e-09 | 30 | 94 | 6 | PS01248 | |
| Domain | Glyco_hormone_CN | 8.37e-09 | 15 | 94 | 5 | IPR006208 | |
| Domain | Cys_knot | 8.37e-09 | 15 | 94 | 5 | PF00007 | |
| Domain | EGF_Lam | 2.00e-08 | 35 | 94 | 6 | SM00180 | |
| Domain | EGF_3 | 2.73e-08 | 235 | 94 | 11 | PS50026 | |
| Domain | Laminin_EGF | 3.35e-08 | 38 | 94 | 6 | IPR002049 | |
| Domain | EGF_CA | 1.83e-07 | 122 | 94 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.08e-07 | 124 | 94 | 8 | IPR001881 | |
| Domain | ASX_HYDROXYL | 7.13e-07 | 100 | 94 | 7 | PS00010 | |
| Domain | Laminin_EGF | 8.36e-07 | 35 | 94 | 5 | PF00053 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.06e-06 | 106 | 94 | 7 | IPR000152 | |
| Domain | Wnt | 2.20e-06 | 19 | 94 | 4 | IPR005817 | |
| Domain | WNT1 | 2.20e-06 | 19 | 94 | 4 | PS00246 | |
| Domain | Wnt_CS | 2.20e-06 | 19 | 94 | 4 | IPR018161 | |
| Domain | wnt | 2.20e-06 | 19 | 94 | 4 | PF00110 | |
| Domain | WNT1 | 2.20e-06 | 19 | 94 | 4 | SM00097 | |
| Domain | Gonadotropin_bsu_CS | 2.44e-06 | 6 | 94 | 3 | IPR018245 | |
| Domain | GLYCO_HORMONE_BETA_1 | 4.26e-06 | 7 | 94 | 3 | PS00261 | |
| Domain | Gonadotropin_bsu | 4.26e-06 | 7 | 94 | 3 | IPR001545 | |
| Domain | GLYCO_HORMONE_BETA_2 | 4.26e-06 | 7 | 94 | 3 | PS00689 | |
| Domain | GHB | 4.26e-06 | 7 | 94 | 3 | SM00068 | |
| Domain | EGF_CA | 4.70e-06 | 86 | 94 | 6 | PF07645 | |
| Domain | LAMININ_IVA | 6.79e-06 | 8 | 94 | 3 | PS51115 | |
| Domain | Laminin_B | 6.79e-06 | 8 | 94 | 3 | PF00052 | |
| Domain | LamB | 6.79e-06 | 8 | 94 | 3 | SM00281 | |
| Domain | Laminin_IV | 6.79e-06 | 8 | 94 | 3 | IPR000034 | |
| Domain | Integrin_dom | 7.02e-06 | 25 | 94 | 4 | IPR032695 | |
| Domain | EGF_Ca-bd_CS | 9.46e-06 | 97 | 94 | 6 | IPR018097 | |
| Domain | EGF_CA | 1.06e-05 | 99 | 94 | 6 | PS01187 | |
| Domain | TSP_1 | 1.62e-05 | 63 | 94 | 5 | PF00090 | |
| Domain | TSP1 | 1.89e-05 | 65 | 94 | 5 | SM00209 | |
| Domain | TSP1_rpt | 1.89e-05 | 65 | 94 | 5 | IPR000884 | |
| Domain | TSP1 | 1.89e-05 | 65 | 94 | 5 | PS50092 | |
| Domain | VWFC_1 | 3.13e-05 | 36 | 94 | 4 | PS01208 | |
| Domain | VWFC_2 | 3.90e-05 | 38 | 94 | 4 | PS50184 | |
| Domain | VWC | 3.90e-05 | 38 | 94 | 4 | SM00214 | |
| Domain | VWF_dom | 5.82e-05 | 42 | 94 | 4 | IPR001007 | |
| Domain | Laminin_N | 6.59e-05 | 16 | 94 | 3 | IPR008211 | |
| Domain | LamNT | 6.59e-05 | 16 | 94 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 6.59e-05 | 16 | 94 | 3 | PS51117 | |
| Domain | Laminin_N | 6.59e-05 | 16 | 94 | 3 | PF00055 | |
| Domain | CUB | 1.07e-04 | 49 | 94 | 4 | PF00431 | |
| Domain | CUB | 1.16e-04 | 50 | 94 | 4 | SM00042 | |
| Domain | - | 1.35e-04 | 52 | 94 | 4 | 2.60.120.290 | |
| Domain | CUB | 1.46e-04 | 53 | 94 | 4 | PS01180 | |
| Domain | - | 1.49e-04 | 4 | 94 | 2 | 1.20.5.630 | |
| Domain | CUB_dom | 1.94e-04 | 57 | 94 | 4 | IPR000859 | |
| Domain | ADAM_spacer1 | 2.03e-04 | 23 | 94 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.03e-04 | 23 | 94 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.31e-04 | 24 | 94 | 3 | IPR013273 | |
| Domain | Laminin_domII | 2.48e-04 | 5 | 94 | 2 | IPR010307 | |
| Domain | Laminin_aI | 2.48e-04 | 5 | 94 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.48e-04 | 5 | 94 | 2 | PF06008 | |
| Domain | Laminin_II | 2.48e-04 | 5 | 94 | 2 | PF06009 | |
| Domain | cEGF | 2.95e-04 | 26 | 94 | 3 | PF12662 | |
| Domain | cEGF | 2.95e-04 | 26 | 94 | 3 | IPR026823 | |
| Domain | hEGF | 3.69e-04 | 28 | 94 | 3 | PF12661 | |
| Domain | VWC | 3.69e-04 | 28 | 94 | 3 | PF00093 | |
| Domain | Integrin_b_cyt | 3.71e-04 | 6 | 94 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 3.71e-04 | 6 | 94 | 2 | PF08725 | |
| Domain | Integrin_bsu_cyt_dom | 3.71e-04 | 6 | 94 | 2 | IPR014836 | |
| Domain | TB | 5.18e-04 | 7 | 94 | 2 | PF00683 | |
| Domain | Integrin_B_tail | 5.18e-04 | 7 | 94 | 2 | SM01242 | |
| Domain | Integrin_bsu_tail | 5.18e-04 | 7 | 94 | 2 | IPR012896 | |
| Domain | GAF | 5.18e-04 | 7 | 94 | 2 | PF01590 | |
| Domain | Integrin_B_tail | 5.18e-04 | 7 | 94 | 2 | PF07965 | |
| Domain | - | 5.29e-04 | 74 | 94 | 4 | 3.40.50.410 | |
| Domain | - | 6.88e-04 | 8 | 94 | 2 | 3.90.290.10 | |
| Domain | GAF | 6.88e-04 | 8 | 94 | 2 | IPR003018 | |
| Domain | INB | 6.88e-04 | 8 | 94 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 6.88e-04 | 8 | 94 | 2 | IPR002369 | |
| Domain | Integrin_beta | 6.88e-04 | 8 | 94 | 2 | PF00362 | |
| Domain | GAF | 6.88e-04 | 8 | 94 | 2 | SM00065 | |
| Domain | Integrin_bsu | 8.82e-04 | 9 | 94 | 2 | IPR015812 | |
| Domain | - | 8.82e-04 | 9 | 94 | 2 | 3.30.450.40 | |
| Domain | TB_dom | 8.82e-04 | 9 | 94 | 2 | IPR017878 | |
| Domain | INTEGRIN_BETA | 8.82e-04 | 9 | 94 | 2 | PS00243 | |
| Domain | PSI_integrin | 8.82e-04 | 9 | 94 | 2 | PF17205 | |
| Domain | Integin_beta_N | 8.82e-04 | 9 | 94 | 2 | IPR033760 | |
| Domain | GAF_dom-like | 8.82e-04 | 9 | 94 | 2 | IPR029016 | |
| Domain | TB | 8.82e-04 | 9 | 94 | 2 | PS51364 | |
| Domain | Znf_FYVE_PHD | 8.83e-04 | 147 | 94 | 5 | IPR011011 | |
| Domain | Galactose-bd-like | 1.30e-03 | 94 | 94 | 4 | IPR008979 | |
| Domain | PSI | 1.41e-03 | 44 | 94 | 3 | IPR016201 | |
| Domain | VWF_A | 1.57e-03 | 99 | 94 | 4 | IPR002035 | |
| Domain | C8 | 1.60e-03 | 12 | 94 | 2 | PF08742 | |
| Domain | TIL | 1.60e-03 | 12 | 94 | 2 | PF01826 | |
| Domain | PSI | 1.60e-03 | 46 | 94 | 3 | SM00423 | |
| Domain | Unchr_dom_Cys-rich | 1.89e-03 | 13 | 94 | 2 | IPR014853 | |
| Domain | C8 | 1.89e-03 | 13 | 94 | 2 | SM00832 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 MATN4 ITGA9 ITGB5 ITGB6 BMP1 ADAMTS9 LTBP4 TNXB FBN3 CAPN15 | 2.81e-11 | 300 | 73 | 15 | M610 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.35e-10 | 84 | 73 | 9 | M7098 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.46e-09 | 11 | 73 | 5 | M158 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.58e-09 | 66 | 73 | 8 | MM15925 | |
| Pathway | WP_FOCAL_ADHESION | 4.00e-08 | 187 | 73 | 10 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 7.19e-08 | 199 | 73 | 10 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.19e-08 | 199 | 73 | 10 | M7253 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | CDKN1A WNT5A WNT6 WNT10B APC2 WNT9A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 EGFR | 9.60e-08 | 325 | 73 | 12 | M12868 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.22e-07 | 76 | 73 | 7 | M27219 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.24e-07 | 46 | 73 | 6 | M239 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 2.12e-07 | 11 | 73 | 4 | M27372 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | CDKN1A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 ITGA9 ITGB5 ITGB6 EGFR TNXB | 3.97e-07 | 302 | 73 | 11 | M39719 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.17e-07 | 30 | 73 | 5 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.67e-07 | 59 | 73 | 6 | M27218 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.04e-07 | 140 | 73 | 8 | M587 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 6.87e-07 | 33 | 73 | 5 | M39503 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | CDKN1A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 ITGA9 ITGB5 ITGB6 EGFR TNXB | 8.47e-07 | 326 | 73 | 11 | MM15917 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 8.65e-07 | 15 | 73 | 4 | M27161 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.11e-06 | 66 | 73 | 6 | M18 | |
| Pathway | WP_PI3KAKT_SIGNALING | CDKN1A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 ITGA9 ITGB5 ITGB6 EGFR TNXB | 1.24e-06 | 339 | 73 | 11 | M39736 |
| Pathway | WP_CANCER_PATHWAYS | CDKN1A WNT5A WNT6 WNT10B APC2 WNT9A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 EGFR NOTCH3 | 1.73e-06 | 507 | 73 | 13 | M48302 |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 2.42e-06 | 19 | 73 | 4 | M47836 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 7.71e-06 | 25 | 73 | 4 | MM14940 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 9.08e-06 | 26 | 73 | 4 | M27239 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 9.08e-06 | 26 | 73 | 4 | M47 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 9.22e-06 | 55 | 73 | 5 | M17807 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.00e-05 | 96 | 73 | 6 | M39834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 1.23e-05 | 28 | 73 | 4 | M47835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.43e-05 | 29 | 73 | 4 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.43e-05 | 29 | 73 | 4 | M47377 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.44e-05 | 154 | 73 | 7 | M39739 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | FOXM1 CDKN1A WNT5A WNT6 WNT10B LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 EGFR | 1.47e-05 | 439 | 73 | 11 | M42563 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.54e-05 | 61 | 73 | 5 | M27103 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.64e-05 | 30 | 73 | 4 | M27772 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.62e-05 | 68 | 73 | 5 | M27303 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 3.76e-05 | 121 | 73 | 6 | M39823 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.84e-05 | 37 | 73 | 4 | M27134 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 3.84e-05 | 37 | 73 | 4 | M47411 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.43e-05 | 258 | 73 | 8 | MM14572 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.80e-05 | 41 | 73 | 4 | M27778 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 7.28e-05 | 84 | 73 | 5 | M3228 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.68e-05 | 44 | 73 | 4 | M26969 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 8.40e-05 | 45 | 73 | 4 | M47412 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 8.60e-05 | 17 | 73 | 3 | M212 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 9.16e-05 | 46 | 73 | 4 | M47409 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.97e-05 | 47 | 73 | 4 | MM14925 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.01e-04 | 90 | 73 | 5 | M631 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.83e-04 | 161 | 73 | 6 | M39770 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 1.98e-04 | 56 | 73 | 4 | M1053 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 2.19e-04 | 23 | 73 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 2.19e-04 | 23 | 73 | 3 | M47720 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 2.60e-04 | 110 | 73 | 5 | M39492 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 3.18e-04 | 26 | 73 | 3 | M47719 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.60e-04 | 118 | 73 | 5 | M39852 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 3.98e-04 | 28 | 73 | 3 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 4.89e-04 | 30 | 73 | 3 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 4.89e-04 | 30 | 73 | 3 | M47718 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 5.79e-04 | 74 | 73 | 4 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 5.79e-04 | 74 | 73 | 4 | M39462 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.42e-04 | 79 | 73 | 4 | M27643 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 8.13e-04 | 213 | 73 | 6 | M18306 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 8.41e-04 | 36 | 73 | 3 | M39699 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 8.65e-04 | 143 | 73 | 5 | M27275 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 8.93e-04 | 83 | 73 | 4 | M8728 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.76e-04 | 85 | 73 | 4 | M16441 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 9.76e-04 | 85 | 73 | 4 | M48315 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 9.87e-04 | 38 | 73 | 3 | M27757 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.07e-03 | 39 | 73 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.07e-03 | 39 | 73 | 3 | MM15165 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.10e-03 | 151 | 73 | 5 | M19428 | |
| Pathway | REACTOME_CGMP_EFFECTS | 1.16e-03 | 10 | 73 | 2 | MM15054 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.21e-03 | 90 | 73 | 4 | M835 | |
| Pathway | WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE | 1.41e-03 | 11 | 73 | 2 | M39446 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.42e-03 | 43 | 73 | 3 | M39565 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.42e-03 | 94 | 73 | 4 | M797 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.52e-03 | 44 | 73 | 3 | MM15878 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 1.66e-03 | 98 | 73 | 4 | M39731 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 1.69e-03 | 12 | 73 | 2 | MM14749 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.83e-03 | 47 | 73 | 3 | M646 | |
| Pathway | KEGG_MELANOGENESIS | 1.85e-03 | 101 | 73 | 4 | M7761 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.92e-03 | 102 | 73 | 4 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.92e-03 | 102 | 73 | 4 | MM15830 | |
| Pathway | REACTOME_GLYCOPROTEIN_HORMONES | 1.99e-03 | 13 | 73 | 2 | MM14830 | |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 1.99e-03 | 13 | 73 | 2 | MM15015 | |
| Pathway | REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY | 1.99e-03 | 13 | 73 | 2 | MM15701 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.44e-03 | 109 | 73 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.61e-03 | 111 | 73 | 4 | M27416 | |
| Pathway | REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS | 2.66e-03 | 15 | 73 | 2 | MM14832 | |
| Pathway | REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS | 2.66e-03 | 15 | 73 | 2 | M27766 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 2.66e-03 | 15 | 73 | 2 | M27273 | |
| Pathway | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | 2.66e-03 | 15 | 73 | 2 | MM14972 | |
| Pathway | REACTOME_ANDROGEN_BIOSYNTHESIS | 2.66e-03 | 15 | 73 | 2 | MM14739 | |
| Pathway | REACTOME_CGMP_EFFECTS | 3.03e-03 | 16 | 73 | 2 | M902 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 3.06e-03 | 116 | 73 | 4 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 3.16e-03 | 117 | 73 | 4 | M39530 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.16e-03 | 117 | 73 | 4 | M19248 | |
| Pathway | PID_NOTCH_PATHWAY | 3.52e-03 | 59 | 73 | 3 | M17 | |
| Pathway | WP_WNT_SIGNALING | 3.87e-03 | 61 | 73 | 3 | MM15893 | |
| Pathway | PID_MYC_REPRESS_PATHWAY | 4.24e-03 | 63 | 73 | 3 | M254 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 4.24e-03 | 63 | 73 | 3 | M39623 | |
| Pubmed | 5.68e-11 | 4 | 97 | 4 | 10651091 | ||
| Pubmed | Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. | 5.68e-11 | 4 | 97 | 4 | 10806203 | |
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 6.93e-11 | 11 | 97 | 5 | 8707838 | |
| Pubmed | IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. | 2.84e-10 | 5 | 97 | 4 | 9271670 | |
| Pubmed | Laminin 5 regulates polycystic kidney cell proliferation and cyst formation. | 2.84e-10 | 5 | 97 | 4 | 16870608 | |
| Pubmed | 6.48e-10 | 16 | 97 | 5 | 17601529 | ||
| Pubmed | 2.28e-09 | 20 | 97 | 5 | 22911573 | ||
| Pubmed | 2.99e-09 | 21 | 97 | 5 | 27856617 | ||
| Pubmed | Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. | 3.94e-09 | 47 | 97 | 6 | 16678101 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 3.95e-09 | 8 | 97 | 4 | 9489770 | |
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 3.95e-09 | 8 | 97 | 4 | 23529140 | |
| Pubmed | 7.09e-09 | 9 | 97 | 4 | 12482924 | ||
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 7.73e-09 | 25 | 97 | 5 | 17170699 | |
| Pubmed | 1.18e-08 | 10 | 97 | 4 | 9034910 | ||
| Pubmed | 1.85e-08 | 11 | 97 | 4 | 10811835 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.85e-08 | 11 | 97 | 4 | 21524702 | |
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 1.85e-08 | 11 | 97 | 4 | 16757171 | |
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 15373767 | ||
| Pubmed | Laminin-5 suppresses chondrogenic differentiation of murine teratocarcinoma cell line ATDC5. | 2.10e-08 | 3 | 97 | 3 | 16165127 | |
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 8113417 | ||
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 27375110 | ||
| Pubmed | Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. | 2.10e-08 | 3 | 97 | 3 | 16537560 | |
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 8012114 | ||
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 22563463 | ||
| Pubmed | Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. | 2.10e-08 | 3 | 97 | 3 | 17482449 | |
| Pubmed | Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. | 2.10e-08 | 3 | 97 | 3 | 8833897 | |
| Pubmed | Expression and chain assembly of human laminin-332 in an insect cell-free translation system. | 2.10e-08 | 3 | 97 | 3 | 18603785 | |
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 33179081 | ||
| Pubmed | Fibroblasts contribute to the deposition of laminin 5 in the extracellular matrix. | 2.10e-08 | 3 | 97 | 3 | 15149852 | |
| Pubmed | Quantitative analysis of laminin 5 gene expression in human keratinocytes. | 2.10e-08 | 3 | 97 | 3 | 15854126 | |
| Pubmed | Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics. | 2.10e-08 | 3 | 97 | 3 | 16179086 | |
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 17137774 | ||
| Pubmed | Differential expression of laminin-5 subunits during incisor and molar development in the mouse. | 2.10e-08 | 3 | 97 | 3 | 10853832 | |
| Pubmed | 2.77e-08 | 12 | 97 | 4 | 9396756 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 7.58e-08 | 15 | 97 | 4 | 15895400 | |
| Pubmed | 7.58e-08 | 15 | 97 | 4 | 9264260 | ||
| Pubmed | 8.40e-08 | 4 | 97 | 3 | 8081888 | ||
| Pubmed | 8.40e-08 | 4 | 97 | 3 | 22673183 | ||
| Pubmed | 8.40e-08 | 4 | 97 | 3 | 21034821 | ||
| Pubmed | Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility. | 8.40e-08 | 4 | 97 | 3 | 19940114 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 9.49e-08 | 79 | 97 | 6 | 18757743 | |
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 1.01e-07 | 16 | 97 | 4 | 12904471 | |
| Pubmed | Wnt family proteins are secreted and associated with the cell surface. | 1.32e-07 | 17 | 97 | 4 | 8167409 | |
| Pubmed | 1.69e-07 | 18 | 97 | 4 | 11311202 | ||
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 14612440 | ||
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 16728390 | ||
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 2468994 | ||
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 28252644 | ||
| Pubmed | WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth. | 2.92e-07 | 50 | 97 | 5 | 18351662 | |
| Pubmed | The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. | 3.28e-07 | 21 | 97 | 4 | 11914369 | |
| Pubmed | Epithelial Wnt10a Is Essential for Tooth Root Furcation Morphogenesis. | 3.28e-07 | 21 | 97 | 4 | 31914354 | |
| Pubmed | 4.00e-07 | 22 | 97 | 4 | 18991257 | ||
| Pubmed | 4.10e-07 | 164 | 97 | 7 | 32409323 | ||
| Pubmed | The beta chorionic gonadotropin-beta luteinizing gene cluster maps to human chromosome 19. | 4.18e-07 | 6 | 97 | 3 | 6204923 | |
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 2422163 | ||
| Pubmed | The beta subunit of human chorionic gonadotropin is encoded by multiple genes. | 4.18e-07 | 6 | 97 | 3 | 6194155 | |
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 1371113 | ||
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 4.18e-07 | 6 | 97 | 3 | 9506922 | |
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 20301304 | ||
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 6319099 | ||
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 23250740 | ||
| Pubmed | 4.64e-07 | 167 | 97 | 7 | 22159717 | ||
| Pubmed | 4.83e-07 | 23 | 97 | 4 | 27362799 | ||
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 4.83e-07 | 23 | 97 | 4 | 23152823 | |
| Pubmed | 6.35e-07 | 175 | 97 | 7 | 28071719 | ||
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 19474061 | ||
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 6690982 | ||
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 10637308 | ||
| Pubmed | 8.11e-07 | 26 | 97 | 4 | 24742657 | ||
| Pubmed | 9.50e-07 | 27 | 97 | 4 | 17804636 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 9.50e-07 | 27 | 97 | 4 | 31541017 | |
| Pubmed | 1.11e-06 | 28 | 97 | 4 | 20940229 | ||
| Pubmed | Ectodermal Wnt signaling regulates abdominal myogenesis during ventral body wall development. | 1.11e-06 | 28 | 97 | 4 | 24394376 | |
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 16005200 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 8872465 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ATRN WNT5A CTSC DCBLD1 LAMA5 ITGA6 LAMB3 LRP1B ITGB5 BMP1 SEC24C CCN1 EGFR NGLY1 NOTCH3 | 1.19e-06 | 1201 | 97 | 15 | 35696571 |
| Pubmed | 1.28e-06 | 29 | 97 | 4 | 22613833 | ||
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 1.28e-06 | 29 | 97 | 4 | 22956684 | |
| Pubmed | 1.28e-06 | 29 | 97 | 4 | 18364260 | ||
| Pubmed | 1.47e-06 | 30 | 97 | 4 | 19282366 | ||
| Pubmed | Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract. | 1.47e-06 | 30 | 97 | 4 | 21936019 | |
| Pubmed | Multistep signaling requirements for pituitary organogenesis in vivo. | 1.47e-06 | 30 | 97 | 4 | 9620855 | |
| Pubmed | 1.47e-06 | 30 | 97 | 4 | 16524929 | ||
| Pubmed | 1.47e-06 | 30 | 97 | 4 | 15880404 | ||
| Pubmed | Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development. | 1.47e-06 | 30 | 97 | 4 | 36305473 | |
| Pubmed | 1.93e-06 | 32 | 97 | 4 | 23154389 | ||
| Pubmed | 2.25e-06 | 75 | 97 | 5 | 20637190 | ||
| Pubmed | 2.49e-06 | 10 | 97 | 3 | 11784026 | ||
| Pubmed | Expression patterns of Wnt genes during development of an anterior part of the chicken eye. | 2.49e-06 | 10 | 97 | 3 | 16258938 | |
| Pubmed | 2.49e-06 | 10 | 97 | 3 | 12591596 | ||
| Pubmed | 2.79e-06 | 35 | 97 | 4 | 30940800 | ||
| Pubmed | 2.79e-06 | 35 | 97 | 4 | 19185060 | ||
| Pubmed | Dual regulation of planar polarization by secreted Wnts and Vangl2 in the developing mouse cochlea. | 2.79e-06 | 35 | 97 | 4 | 32907846 | |
| Pubmed | Expression of Wnt signalling pathway genes during tooth development. | 3.41e-06 | 11 | 97 | 3 | 10415363 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 3.41e-06 | 11 | 97 | 3 | 23472759 | |
| Pubmed | 3.41e-06 | 11 | 97 | 3 | 12802069 | ||
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 3.50e-06 | 37 | 97 | 4 | 35831952 | |
| Pubmed | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. | 3.90e-06 | 38 | 97 | 4 | 21041481 | |
| Pubmed | 3.90e-06 | 38 | 97 | 4 | 23190887 | ||
| Pubmed | Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. | 4.34e-06 | 39 | 97 | 4 | 16510873 | |
| Interaction | FBXO2 interactions | ATRN WNT10B LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 LRP1B ITGB5 BMP1 EGFR LTBP4 NOTCH3 | 5.90e-08 | 411 | 94 | 13 | int:FBXO2 |
| Interaction | NOTCH2 interactions | WNT5A WNT10B ZNF865 ZNF497 SEC24C CCN1 EGFR ADAMTS9 FIZ1 ADAMTS15 LTBP4 NOTCH3 ZNF646 | 8.24e-08 | 423 | 94 | 13 | int:NOTCH2 |
| Interaction | LAMC2 interactions | 2.58e-07 | 30 | 94 | 5 | int:LAMC2 | |
| Interaction | OIT3 interactions | 5.80e-07 | 65 | 94 | 6 | int:OIT3 | |
| Interaction | IGFL3 interactions | 1.36e-06 | 75 | 94 | 6 | int:IGFL3 | |
| Interaction | COL7A1 interactions | 5.21e-06 | 25 | 94 | 4 | int:COL7A1 | |
| Interaction | DEFA1 interactions | 7.34e-06 | 100 | 94 | 6 | int:DEFA1 | |
| Interaction | PRG2 interactions | 7.42e-06 | 285 | 94 | 9 | int:PRG2 | |
| Interaction | EDN3 interactions | 1.14e-05 | 108 | 94 | 6 | int:EDN3 | |
| Interaction | CFC1 interactions | 2.75e-05 | 126 | 94 | 6 | int:CFC1 | |
| Interaction | FBXO6 interactions | ATRN RARS1 CTSC LAMA3 LAMA5 ITGA6 LAMB3 HUWE1 ITGB5 EGFR SCARA5 NGLY1 LTBP4 | 2.78e-05 | 717 | 94 | 13 | int:FBXO6 |
| Interaction | ZBTB17 interactions | 3.01e-05 | 77 | 94 | 5 | int:ZBTB17 | |
| Interaction | FBLN1 interactions | 3.14e-05 | 129 | 94 | 6 | int:FBLN1 | |
| Interaction | IGSF5 interactions | 3.45e-05 | 14 | 94 | 3 | int:IGSF5 | |
| Interaction | CRISP2 interactions | 3.57e-05 | 40 | 94 | 4 | int:CRISP2 | |
| Interaction | SLURP1 interactions | 5.82e-05 | 144 | 94 | 6 | int:SLURP1 | |
| Interaction | ZNF408 interactions | 6.05e-05 | 145 | 94 | 6 | int:ZNF408 | |
| Interaction | LAMB3 interactions | 6.37e-05 | 90 | 94 | 5 | int:LAMB3 | |
| Interaction | LY86 interactions | 7.05e-05 | 217 | 94 | 7 | int:LY86 | |
| Interaction | ELSPBP1 interactions | 7.08e-05 | 92 | 94 | 5 | int:ELSPBP1 | |
| Interaction | OS9 interactions | 7.47e-05 | 219 | 94 | 7 | int:OS9 | |
| Interaction | PATE1 interactions | 8.01e-05 | 49 | 94 | 4 | int:PATE1 | |
| Interaction | FOXD4L6 interactions | 8.01e-05 | 49 | 94 | 4 | int:FOXD4L6 | |
| Interaction | BTNL2 interactions | 8.76e-05 | 155 | 94 | 6 | int:BTNL2 | |
| Interaction | RASL11B interactions | 9.02e-05 | 19 | 94 | 3 | int:RASL11B | |
| Interaction | MFAP5 interactions | 1.01e-04 | 52 | 94 | 4 | int:MFAP5 | |
| Interaction | SDF2L1 interactions | 1.32e-04 | 322 | 94 | 8 | int:SDF2L1 | |
| Interaction | WDR25 interactions | 1.55e-04 | 58 | 94 | 4 | int:WDR25 | |
| Interaction | BMP1 interactions | 1.72e-04 | 111 | 94 | 5 | int:BMP1 | |
| Interaction | PTPRK interactions | 1.81e-04 | 177 | 94 | 6 | int:PTPRK | |
| Interaction | NTN5 interactions | 1.85e-04 | 24 | 94 | 3 | int:NTN5 | |
| Interaction | LAMA3 interactions | 2.14e-04 | 63 | 94 | 4 | int:LAMA3 | |
| Interaction | CEACAM8 interactions | 2.38e-04 | 119 | 94 | 5 | int:CEACAM8 | |
| GeneFamily | Laminin subunits | 1.06e-07 | 12 | 71 | 4 | 626 | |
| GeneFamily | Wnt family|Endogenous ligands | 8.09e-07 | 19 | 71 | 4 | 360 | |
| GeneFamily | CD molecules|Integrin beta subunits | 5.38e-04 | 9 | 71 | 2 | 1159 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.23e-03 | 18 | 71 | 2 | 1160 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.49e-03 | 19 | 71 | 2 | 50 | |
| GeneFamily | Zinc fingers MYND-type | 3.04e-03 | 21 | 71 | 2 | 87 | |
| GeneFamily | Phosphodiesterases | 3.97e-03 | 24 | 71 | 2 | 681 | |
| GeneFamily | Fibrinogen C domain containing | 4.30e-03 | 25 | 71 | 2 | 554 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 5.01e-03 | 27 | 71 | 2 | 1253 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.98e-03 | 718 | 71 | 8 | 28 | |
| Coexpression | NABA_MATRISOME | WNT5A CTSC WNT6 WNT10B WNT9A LAMA3 LAMA5 LAMB3 PAPLN LAMC2 MATN4 BMP1 CCN1 ADAMTS9 FCN1 ADAMTS15 CHRD NGLY1 LTBP4 MUC5AC TNXB FBN3 | 1.85e-11 | 1026 | 97 | 22 | M5889 |
| Coexpression | NABA_MATRISOME | WNT5A CTSC WNT6 WNT10B WNT9A LAMA3 LAMA5 LAMB3 PAPLN LAMC2 MATN4 BMP1 CCN1 ADAMTS9 FCN1 ADAMTS15 CHRD NGLY1 LTBP4 MUC5AC TNXB | 9.76e-11 | 1008 | 97 | 21 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.11e-09 | 196 | 97 | 10 | M3008 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.00e-08 | 23 | 97 | 5 | M48001 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.95e-08 | 191 | 97 | 9 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 7.74e-08 | 275 | 97 | 10 | M5884 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.71e-07 | 40 | 97 | 5 | M5887 | |
| Coexpression | NABA_CORE_MATRISOME | 7.41e-07 | 270 | 97 | 9 | MM17057 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 8.16e-07 | 20 | 97 | 4 | MM17053 | |
| Coexpression | ZHANG_GATA6_TARGETS_DN | 3.71e-06 | 63 | 97 | 5 | M1778 | |
| Coexpression | ZHANG_GATA6_TARGETS_DN | 4.33e-06 | 65 | 97 | 5 | MM1226 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | TCF15 WNT5A WNT6 WNT9A LAMC2 MATN4 ITGA9 ITGB5 LHX2 CCN1 EGFR ADAMTS15 CHRD PDE5A EN2 | 9.30e-06 | 1074 | 97 | 15 | M1941 |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 9.46e-06 | 131 | 97 | 6 | M40316 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | WNT5A CTSC WNT6 WNT10B WNT9A BMP1 ADAMTS9 FCN1 ADAMTS15 CHRD NGLY1 MUC5AC | 1.82e-05 | 738 | 97 | 12 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | WNT5A CTSC WNT6 WNT10B WNT9A BMP1 ADAMTS9 FCN1 ADAMTS15 CHRD NGLY1 MUC5AC | 2.16e-05 | 751 | 97 | 12 | M5885 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN | 5.07e-05 | 457 | 97 | 9 | M14507 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 7.27e-05 | 479 | 97 | 9 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 7.74e-05 | 483 | 97 | 9 | MM1082 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP | 1.02e-04 | 200 | 97 | 6 | M4663 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.02e-04 | 200 | 97 | 6 | M5930 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 1.02e-04 | 200 | 97 | 6 | M5915 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | 1.47e-04 | 307 | 97 | 7 | M39058 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP | 1.66e-04 | 74 | 97 | 4 | M515 | |
| Coexpression | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN | 2.05e-04 | 31 | 97 | 3 | M3732 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNPROG | 2.12e-04 | 229 | 97 | 6 | M39062 | |
| Coexpression | LI_PROSTATE_CANCER_EPIGENETIC | 2.25e-04 | 32 | 97 | 3 | M10861 | |
| Coexpression | DELYS_THYROID_CANCER_UP | 2.51e-04 | 445 | 97 | 8 | M3645 | |
| Coexpression | HINATA_NFKB_TARGETS_KERATINOCYTE_UP | 2.71e-04 | 84 | 97 | 4 | M11951 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 2.81e-04 | 574 | 97 | 9 | M39056 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | 2.81e-04 | 574 | 97 | 9 | M8215 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | THSD7A WNT5A LAMA5 ITGB5 BMP1 CCN1 EGFR SCARA5 CSMD1 LTBP4 TNXB NOTCH3 | 1.14e-06 | 466 | 95 | 12 | GSM777050_500 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | THSD7A WNT5A ITGB5 BMP1 CCN1 EGFR SCARA5 CSMD1 LTBP4 TNXB NOTCH3 | 6.00e-06 | 455 | 95 | 11 | GSM777055_500 |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | 1.28e-05 | 402 | 95 | 10 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_500 | 2.59e-05 | 193 | 95 | 7 | gudmap_developingKidney_e11.5_ureteric bud_500_k3 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | CDKN1A WNT5A ITGB5 BMP1 CCN1 EGFR SCARA5 ADAMTS15 LTBP4 TNXB | 2.61e-05 | 437 | 95 | 10 | GSM777046_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 3.05e-05 | 445 | 95 | 10 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | CDKN1A PDE2A DCBLD1 LAMA3 LAMA5 ITGA6 CCN1 ADAMTS9 FGD5 LTBP4 | 3.96e-05 | 459 | 95 | 10 | GSM777037_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 9.87e-05 | 165 | 95 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | 1.24e-04 | 426 | 95 | 9 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.25e-04 | 108 | 95 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.96e-04 | 453 | 95 | 9 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 2.06e-04 | 456 | 95 | 9 | GSM777032_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 2.29e-04 | 364 | 95 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000 | CDKN1A AEN WNT6 DCBLD1 LAMA5 LAMC2 CHST11 CCN1 DROSHA FIZ1 NOTCH3 DNMT3B | 2.71e-04 | 813 | 95 | 12 | gudmap_developingKidney_e11.5_ureteric bud_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 2.97e-04 | 130 | 95 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-09 | 145 | 97 | 8 | 80684ec249fa445c1b35f94608a4a6824d53f2d9 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-09 | 145 | 97 | 8 | cb534333fba44b241b14fb0d7b74e843f4e7f9f8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-09 | 166 | 97 | 8 | 2887f4f0c218cbcbcc82eef27aa4ee714b35cddb | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-09 | 166 | 97 | 8 | 1cc291a04f4144abba4aca7badeb7776db05d903 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-08 | 193 | 97 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.26e-08 | 198 | 97 | 8 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-08 | 198 | 97 | 8 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-08 | 199 | 97 | 8 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-08 | 199 | 97 | 8 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.36e-08 | 200 | 97 | 8 | 06b59ee536414d1f73c1e17cdfd7c3f2259b9bef | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.19e-07 | 176 | 97 | 7 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.19e-07 | 176 | 97 | 7 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 1.23e-07 | 177 | 97 | 7 | 22b7cda748cf5e665be54ca5bae89f0c130d5e7f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.28e-07 | 178 | 97 | 7 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-07 | 180 | 97 | 7 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.55e-07 | 183 | 97 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-07 | 184 | 97 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-07 | 188 | 97 | 7 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-07 | 188 | 97 | 7 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-07 | 188 | 97 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-07 | 188 | 97 | 7 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 189 | 97 | 7 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 189 | 97 | 7 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 2.00e-07 | 190 | 97 | 7 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 2.00e-07 | 190 | 97 | 7 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-07 | 190 | 97 | 7 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 2.00e-07 | 190 | 97 | 7 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-07 | 190 | 97 | 7 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-07 | 190 | 97 | 7 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-07 | 190 | 97 | 7 | c1bfc1960a3df49c0f459454a7363804c32418ee | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-07 | 191 | 97 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-07 | 191 | 97 | 7 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-07 | 192 | 97 | 7 | c3707243c5590d852c9f28429c96f50a1fa6b0dc | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-07 | 192 | 97 | 7 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-07 | 192 | 97 | 7 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-07 | 193 | 97 | 7 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-07 | 193 | 97 | 7 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-07 | 193 | 97 | 7 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-07 | 193 | 97 | 7 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-07 | 195 | 97 | 7 | a486a7acea0e91048cc48afa0dbd3926d30bc217 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-07 | 195 | 97 | 7 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-07 | 196 | 97 | 7 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-07 | 196 | 97 | 7 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.55e-07 | 197 | 97 | 7 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-07 | 197 | 97 | 7 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-07 | 197 | 97 | 7 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.64e-07 | 198 | 97 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.64e-07 | 198 | 97 | 7 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.64e-07 | 198 | 97 | 7 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.73e-07 | 199 | 97 | 7 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-07 | 199 | 97 | 7 | a60880d6b73b2f33b33790873b8c1e8096863908 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-07 | 200 | 97 | 7 | 3e6730c9ed7003a4acf501f699a4965a7a50f946 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-07 | 200 | 97 | 7 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.83e-07 | 200 | 97 | 7 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.83e-07 | 200 | 97 | 7 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 2.83e-07 | 200 | 97 | 7 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.83e-07 | 200 | 97 | 7 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 2.83e-07 | 200 | 97 | 7 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.25e-06 | 157 | 97 | 6 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-06 | 170 | 97 | 6 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_late|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.98e-06 | 170 | 97 | 6 | 83320d37f0fc74e492cfe3de18f5c499eaa9fd3e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-06 | 170 | 97 | 6 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.12e-06 | 172 | 97 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.19e-06 | 173 | 97 | 6 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.19e-06 | 173 | 97 | 6 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-06 | 174 | 97 | 6 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-06 | 175 | 97 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-06 | 175 | 97 | 6 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.34e-06 | 175 | 97 | 6 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-06 | 176 | 97 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 2.42e-06 | 176 | 97 | 6 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-06 | 176 | 97 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.50e-06 | 177 | 97 | 6 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-06 | 177 | 97 | 6 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.67e-06 | 179 | 97 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-06 | 179 | 97 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-06 | 179 | 97 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-06 | 179 | 97 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 180 | 97 | 6 | f9b7d5eb7b6ea72253c89bdc351ad2b4a53f7d8e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 180 | 97 | 6 | 53db6032eda0e590ae7e01c9c3b472785ea6782f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 180 | 97 | 6 | 28bc10b9d0e4430b952260014d8a6ff337860ac6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-06 | 181 | 97 | 6 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-06 | 181 | 97 | 6 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-06 | 181 | 97 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 181 | 97 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 2.85e-06 | 181 | 97 | 6 | 33938e6521712058312879f84f4ae381c2bfc379 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-06 | 181 | 97 | 6 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.94e-06 | 182 | 97 | 6 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-06 | 182 | 97 | 6 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-06 | 182 | 97 | 6 | e6a734fb29105093d4cbfc3d0619a825b66da034 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-06 | 182 | 97 | 6 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-06 | 182 | 97 | 6 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-06 | 182 | 97 | 6 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-06 | 182 | 97 | 6 | ccc313ecc0bfd8e2c6bb83a565b427b2310485ec | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 2.94e-06 | 182 | 97 | 6 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-06 | 182 | 97 | 6 | b9f758961fb4a586ae86fa0b25edb8ce4616d644 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.03e-06 | 183 | 97 | 6 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.03e-06 | 183 | 97 | 6 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.03e-06 | 183 | 97 | 6 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.03e-06 | 183 | 97 | 6 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.13e-07 | 50 | 63 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Trachea genes. | CDKN1A ACR CTSC LAMA5 ITGA6 ITGB5 BMP1 CCN1 EGFR PLA2G2A TNXB NOTCH3 | 4.18e-06 | 415 | 63 | 12 | MODULE_6 |
| Computational | Placenta genes. | CDKN1A CTSC CGB3 LAMA5 ITGB5 BMP1 CCN1 EGFR PLA2G2A TNXB NOTCH3 | 6.80e-05 | 463 | 63 | 11 | MODULE_38 |
| Computational | Genes in the cancer module 123. | 9.02e-05 | 247 | 63 | 8 | MODULE_123 | |
| Computational | Genes in the cancer module 275. | 1.02e-04 | 16 | 63 | 3 | MODULE_275 | |
| Computational | Adhesion molecules. | 1.68e-04 | 141 | 63 | 6 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.02e-04 | 50 | 63 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Neighborhood of CDH3 | 5.08e-04 | 27 | 63 | 3 | GNF2_CDH3 | |
| Computational | Neighborhood of SERPINB5 | 5.66e-04 | 28 | 63 | 3 | GNF2_SERPINB5 | |
| Computational | Lung genes. | 8.94e-04 | 434 | 63 | 9 | MODULE_5 | |
| Computational | Genes in the cancer module 153. | 1.01e-03 | 34 | 63 | 3 | MODULE_153 | |
| Computational | Immune (humoral) and inflammatory response. | 1.18e-03 | 546 | 63 | 10 | MODULE_84 | |
| Computational | Intermediate filaments and keratins. | 1.21e-03 | 80 | 63 | 4 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 1.21e-03 | 80 | 63 | 4 | MODULE_297 | |
| Computational | DRG (dorsal root ganglia) genes. | 1.71e-03 | 384 | 63 | 8 | MODULE_2 | |
| Drug | Rgd Peptide | LAMA3 LAMA5 ITGA6 LAMC2 ITGA9 ITGB5 ITGB6 CCN1 UHRF2 TNXB FBN3 | 6.09e-09 | 239 | 97 | 11 | CID000104802 |
| Drug | BM165 | 9.98e-08 | 11 | 97 | 4 | CID003352881 | |
| Drug | trypanothione disulfide | 2.32e-06 | 140 | 97 | 7 | CID000115098 | |
| Drug | Sikvav | 3.08e-06 | 24 | 97 | 4 | CID005487517 | |
| Drug | 2,4-diaminopyrimidine | 3.39e-06 | 54 | 97 | 5 | CID000067431 | |
| Drug | kalinin | 3.72e-06 | 55 | 97 | 5 | CID000032518 | |
| Drug | pyrazolo(3,4-d)pyrimidine | 3.93e-06 | 98 | 97 | 6 | ctd:C014175 | |
| Drug | lysophosphatidic acid | 4.44e-06 | 57 | 97 | 5 | ctd:C032881 | |
| Drug | AC1L9INI | 5.28e-06 | 59 | 97 | 5 | CID000445839 | |
| Drug | N-acetylhexosamine | FOXM1 CTSC ITGA6 ITGA9 ITGB5 ITGB6 EGFR FCN1 HPS4 NGLY1 MUC5AC | 5.41e-06 | 472 | 97 | 11 | CID000000899 |
| Drug | AC1L1C2F | 7.67e-06 | 110 | 97 | 6 | CID000001711 | |
| Drug | palbociclib | 8.68e-06 | 171 | 97 | 7 | ctd:C500026 | |
| Drug | Vitallium | 9.86e-06 | 244 | 97 | 8 | ctd:D014800 | |
| Drug | AC1L1G72 | 1.21e-05 | 11 | 97 | 3 | CID000003553 | |
| Drug | dysprosium | 1.61e-05 | 74 | 97 | 5 | CID000023912 | |
| Drug | sphingosine 1-phosphate | 1.84e-05 | 37 | 97 | 4 | ctd:C060506 | |
| Drug | Ikvav | 2.04e-05 | 38 | 97 | 4 | CID000131343 | |
| Drug | rhamnose | 2.15e-05 | 356 | 97 | 9 | CID000000840 | |
| Drug | YIGSR | 2.22e-05 | 79 | 97 | 5 | CID000123977 | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.24e-05 | 198 | 97 | 7 | 6261_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.32e-05 | 199 | 97 | 7 | 2292_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.32e-05 | 199 | 97 | 7 | 4297_DN | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 2.32e-05 | 199 | 97 | 7 | 2822_UP | |
| Drug | Mifepristone | CDKN1A PDE2A WNT5A CTSC LAMA3 LAMA5 ITGA6 LAMC2 KMT2D EGFR ADAMTS9 | 2.37e-05 | 553 | 97 | 11 | ctd:D015735 |
| Drug | calcium carbonate | 2.63e-05 | 203 | 97 | 7 | CID000010112 | |
| Drug | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride | 2.64e-05 | 14 | 97 | 3 | ctd:C439285 | |
| Drug | Grgds | 2.82e-05 | 83 | 97 | 5 | CID000123811 | |
| Drug | dl-Lysine | 3.41e-05 | 290 | 97 | 8 | CID000000866 | |
| Drug | poly-N-acetyllactosamine | 3.75e-05 | 88 | 97 | 5 | CID000119547 | |
| Drug | dermatan sulfate | 4.40e-05 | 220 | 97 | 7 | CID000032756 | |
| Drug | Mustard Gas | FOXM1 CDKN1A LAMA3 LAMA5 ITGA6 LAMB3 LAMC2 HUWE1 ITGB5 BMP1 CCN1 FCN1 OSBPL7 GPSM2 TNXB NOTCH3 DNMT3B | 4.75e-05 | 1341 | 97 | 17 | ctd:D009151 |
| Drug | BRL 50481 | 4.88e-05 | 17 | 97 | 3 | CID002921148 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 5.36e-05 | 155 | 97 | 6 | 6817_DN | |
| Drug | 2 VES | 5.37e-05 | 3 | 97 | 2 | CID009823454 | |
| Drug | sulindac sulfone | 8.31e-05 | 54 | 97 | 4 | ctd:C025463 | |
| Drug | Rgds Peptide | 9.12e-05 | 106 | 97 | 5 | CID000107775 | |
| Drug | ALT-711 | 9.43e-05 | 21 | 97 | 3 | CID000216304 | |
| Drug | seocalcitol | 9.84e-05 | 173 | 97 | 6 | ctd:C078903 | |
| Drug | Gdrgdsp | 1.04e-04 | 109 | 97 | 5 | CID000115346 | |
| Drug | 2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone | 1.07e-04 | 4 | 97 | 2 | ctd:C529061 | |
| Drug | Lysophosphatidylcholines | 1.09e-04 | 22 | 97 | 3 | ctd:D008244 | |
| Drug | boron | 1.16e-04 | 257 | 97 | 7 | CID005462311 | |
| Drug | LG 5 | 1.26e-04 | 60 | 97 | 4 | CID011840957 | |
| Drug | B-Ms | 1.29e-04 | 114 | 97 | 5 | CID000445091 | |
| Drug | AC1O0B8G | 1.31e-04 | 262 | 97 | 7 | CID000091605 | |
| Drug | Clioquinol | 1.43e-04 | 62 | 97 | 4 | ctd:D007464 | |
| Drug | Betamethasone-d5 | CDKN1A RARS1 ACR LAMA3 LAMA5 ITGA6 LAMC2 CHST11 ITGA9 ITGB5 ITGB6 ACTL7B CGB1 EGFR MUC5AC FBN3 | 1.64e-04 | 1340 | 97 | 16 | CID000003003 |
| Drug | indole-3-acetyl-l-valine | 1.72e-04 | 65 | 97 | 4 | CID000446641 | |
| Drug | N-methylformamide | 1.82e-04 | 66 | 97 | 4 | CID000031254 | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; PC3; HT_HG-U133A | 1.84e-04 | 194 | 97 | 6 | 4537_UP | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 5990_UP | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 5277_DN | |
| Drug | AC1MMZLG | 1.93e-04 | 67 | 97 | 4 | CID003269220 | |
| Drug | probucol; Up 200; 10uM; MCF7; HG-U133A | 1.94e-04 | 196 | 97 | 6 | 592_UP | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 4655_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; PC3; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 3726_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 3571_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 3742_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 4207_DN | |
| Drug | Iodixanol [92339-11-2]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 3362_UP | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 5394_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 6663_DN | |
| Drug | rofecoxib; Down 200; 10uM; MCF7; HG-U133A | 2.05e-04 | 198 | 97 | 6 | 251_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 5476_DN | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 3722_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 5295_UP | |
| Drug | ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 4462_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 3706_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 5516_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 4115_UP | |
| Drug | 2,3-pentanedione | 2.29e-04 | 129 | 97 | 5 | ctd:C013186 | |
| Drug | 2-naphthamide | 2.53e-04 | 29 | 97 | 3 | CID000075245 | |
| Drug | AC1L1B58 | 2.53e-04 | 29 | 97 | 3 | CID000001288 | |
| Drug | Teglicar [inn] | 2.53e-04 | 29 | 97 | 3 | CID006433111 | |
| Drug | BPDQ | 2.66e-04 | 6 | 97 | 2 | CID000002426 | |
| Drug | 5,7,3'-trihydroxy-3,4'-dimethoxyflavone | 2.66e-04 | 6 | 97 | 2 | ctd:C549753 | |
| Drug | piperlonguminine | 2.66e-04 | 6 | 97 | 2 | ctd:C498077 | |
| Drug | 3-ISOBUTYL-1-METHYLXANTHINE | 2.66e-04 | 6 | 97 | 2 | DB07954 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.96e-10 | 28 | 93 | 6 | DOID:5409 (is_implicated_in) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 3.21e-09 | 7 | 93 | 4 | DOID:3209 (is_implicated_in) | |
| Disease | Junctional epidermolysis bullosa | 3.03e-08 | 3 | 93 | 3 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 3.03e-08 | 3 | 93 | 3 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 3.03e-08 | 3 | 93 | 3 | 226700 | |
| Disease | junctional epidermolysis bullosa Herlitz type (implicated_via_orthology) | 3.03e-08 | 3 | 93 | 3 | DOID:0060737 (implicated_via_orthology) | |
| Disease | Epidermolysis Bullosa Progressiva | 1.21e-07 | 4 | 93 | 3 | C0079297 | |
| Disease | Herlitz Disease | 1.21e-07 | 4 | 93 | 3 | C0079683 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 3.02e-07 | 5 | 93 | 3 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 3.02e-07 | 5 | 93 | 3 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 3.02e-07 | 5 | 93 | 3 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 6.02e-07 | 6 | 93 | 3 | C0079301 | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 1.05e-06 | 7 | 93 | 3 | C0399367 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.70e-06 | 63 | 93 | 5 | DOID:0050866 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 6.29e-06 | 525 | 93 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 6.29e-06 | 525 | 93 | 10 | C1257931 | |
| Disease | Mammary Neoplasms | 6.51e-06 | 527 | 93 | 10 | C1458155 | |
| Disease | Breast Carcinoma | 7.79e-06 | 538 | 93 | 10 | C0678222 | |
| Disease | Squamous cell carcinoma of esophagus | 1.29e-05 | 95 | 93 | 5 | C0279626 | |
| Disease | Lung Neoplasms | 2.14e-05 | 265 | 93 | 7 | C0024121 | |
| Disease | Malignant neoplasm of lung | 2.19e-05 | 266 | 93 | 7 | C0242379 | |
| Disease | pulse pressure measurement | CDKN1A TEX2 LAMA5 CHST11 UPF3A ITGA9 ITGB5 CCN1 OSBPL7 ADAMTS15 FGD5 SNX11 LNX1 NOTCH3 DNMT3B | 2.89e-05 | 1392 | 93 | 15 | EFO_0005763 |
| Disease | Malignant neoplasm of breast | FOXM1 PDE2A WNT10B APC2 ITGA9 BMP1 KMT2D EGFR FGD5 NOTCH3 TP73 DNMT3B ZNF646 | 3.20e-05 | 1074 | 93 | 13 | C0006142 |
| Disease | Amelogenesis imperfecta type 1 | 9.77e-05 | 5 | 93 | 2 | cv:C0399367 | |
| Disease | cholesteryl ester 22:6 measurement | 1.41e-04 | 32 | 93 | 3 | EFO_0010350 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.01e-04 | 169 | 93 | 5 | DOID:3908 (is_marker_for) | |
| Disease | cancer (implicated_via_orthology) | 2.09e-04 | 268 | 93 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Neoplasm Recurrence, Local | 2.55e-04 | 39 | 93 | 3 | C0027643 | |
| Disease | tenascin measurement | 4.35e-04 | 10 | 93 | 2 | EFO_0008296 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 5.03e-04 | 49 | 93 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 5.93e-04 | 121 | 93 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Papilloma | 6.35e-04 | 12 | 93 | 2 | C0030354 | |
| Disease | Papillomatosis | 6.35e-04 | 12 | 93 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 6.35e-04 | 12 | 93 | 2 | C0205874 | |
| Disease | periodontitis | 7.14e-04 | 223 | 93 | 5 | EFO_0000649 | |
| Disease | Prostatic Neoplasms | 7.41e-04 | 616 | 93 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 7.41e-04 | 616 | 93 | 8 | C0376358 | |
| Disease | illegal drug consumption | 7.49e-04 | 13 | 93 | 2 | EFO_0005431 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 8.72e-04 | 14 | 93 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 9.56e-04 | 61 | 93 | 3 | DOID:3587 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.95e-04 | 139 | 93 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.10e-03 | 64 | 93 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Amelogenesis imperfecta | 1.30e-03 | 17 | 93 | 2 | cv:C0002452 | |
| Disease | serum IgG glycosylation measurement | 1.35e-03 | 523 | 93 | 7 | EFO_0005193 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.52e-03 | 156 | 93 | 4 | C0007131 | |
| Disease | factor VIII measurement, Ischemic stroke | 1.62e-03 | 19 | 93 | 2 | EFO_0004630, HP_0002140 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 1.62e-03 | 19 | 93 | 2 | DOID:2876 (is_marker_for) | |
| Disease | response to mitochondrial complex I inhibitor | 1.62e-03 | 19 | 93 | 2 | EFO_0600033 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.67e-03 | 74 | 93 | 3 | DOID:3748 (is_marker_for) | |
| Disease | Glioblastoma | 2.02e-03 | 79 | 93 | 3 | C0017636 | |
| Disease | triacylglycerol 58:9 measurement | 2.18e-03 | 22 | 93 | 2 | EFO_0010443 | |
| Disease | arginine measurement | 2.38e-03 | 23 | 93 | 2 | EFO_0020990 | |
| Disease | sensory peripheral neuropathy, remission | 2.38e-03 | 23 | 93 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | Giant Cell Glioblastoma | 2.40e-03 | 84 | 93 | 3 | C0334588 | |
| Disease | asthma | 2.58e-03 | 751 | 93 | 8 | MONDO_0004979 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.59e-03 | 24 | 93 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | corpus collosum mid-posterior volume measurement | 2.81e-03 | 25 | 93 | 2 | EFO_0010300 | |
| Disease | brain cancer (implicated_via_orthology) | 3.04e-03 | 26 | 93 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | myeloperoxidase measurement | 3.04e-03 | 26 | 93 | 2 | EFO_0005243 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KQCLRAGSGSAPCSR | 81 | Q8WTP8 | |
| DGVRAECTSAGCFPK | 161 | A8MVZ5 | |
| GDVRQNPCGSKACRR | 6 | P38936 | |
| PELTAACLGRCQDTG | 316 | Q9Y614 | |
| GDERPSCRVISCGSL | 2611 | Q96PZ7 | |
| LEDGCLSCGRKNPVS | 431 | Q9UBC3 | |
| DNATCDGPCGLRFRQ | 21 | P10323 | |
| ALKGICRAQSEGRPC | 86 | O00622 | |
| ALCRRSTTDCGGPKD | 141 | A6NKQ9 | |
| DGFNGDTPLICACRR | 36 | Q5VYY1 | |
| ARDPLLCRGGTCTNT | 1076 | Q75N90 | |
| KLSPGGACVGRNECR | 1796 | Q75N90 | |
| APDKRRCEAACGGFL | 581 | P13497 | |
| CRGSAGQRTVPACDA | 866 | Q8TE58 | |
| GGRGSPKDATDRCCV | 51 | P14555 | |
| ADKPSPCGRSCGRVS | 386 | O75808 | |
| TAPVSSCDLGGRDLC | 691 | Q96RG2 | |
| GERLCKSGDCRAGVS | 31 | P81274 | |
| GRCIPSGGLCDNKDD | 2901 | Q9NZR2 | |
| RCLCPEGRQLQADGK | 361 | O95460 | |
| SAPEEALRCCRQAGK | 501 | Q8NEM0 | |
| KPRITGRQCDRCASG | 1381 | Q16787 | |
| NNPEKLLETRCGRCG | 296 | Q96IV0 | |
| AEAKECDRPCVNGGR | 96 | O75882 | |
| EACPDGRKENGCLSG | 316 | Q9NQG7 | |
| ALCRRSTTDCGGPKD | 111 | P0DN87 | |
| LNCSREARGSSRCGP | 221 | Q53F39 | |
| GRKASETCSGCNIAR | 511 | O43439 | |
| GERCDTPANLLAKGC | 56 | P18564 | |
| DGTRAPINGCCSLDA | 926 | O00408 | |
| SEDCFPLLDGCRKNR | 836 | O76074 | |
| LNKCSNGRLPCVDRG | 31 | Q6ZNL6 | |
| GPRCSQSLARDACES | 726 | Q9UM47 | |
| PSGEFAVCESCKLGR | 36 | Q8NG35 | |
| KRRSQDGCPDGCASL | 141 | Q8TBB1 | |
| SSDRAALCAGCGGKI | 46 | P50458 | |
| CTNDRKDECRTPRGT | 5066 | P98088 | |
| DLRQKTACGAPSGIC | 521 | P23229 | |
| TQGNACRKDPRVGRC | 501 | O15230 | |
| DSGQCKCRPNVTGRR | 1546 | O15230 | |
| CESDRERGNKACSPC | 3361 | Q7Z6Z7 | |
| NLCREAEGKPLCSGR | 511 | P18084 | |
| RPGCRLHSCSEAEKG | 76 | Q8NDY4 | |
| EGRICACPGRDRKAD | 291 | O15350 | |
| CATGPRNCKDLLDRG | 111 | O00602 | |
| KNRGTSCGKTCREDR | 106 | Q13797 | |
| TCEPGKVCGASAGRR | 56 | Q9H8W2 | |
| AQQCSGRCRGKSPSD | 216 | P00533 | |
| GDVANKATLCARRGC | 476 | O95996 | |
| KARRDKCGVCGGDNS | 736 | Q9P2N4 | |
| RAGQSEAGCCLLERK | 546 | Q53HC5 | |
| ALCRRSTTDCGGPKD | 111 | P0DN86 | |
| LSGDGAVRCDTPANC | 16 | P53634 | |
| CSACPKGFRDSTGLL | 81 | Q96SL8 | |
| ACDSGFRLSPQGTRC | 571 | Q8N2S1 | |
| PGALCEQKRETCADG | 156 | Q08050 | |
| CDKASGRCLCRPGLT | 546 | Q13751 | |
| RERDRCLPCNCNSKG | 76 | Q13753 | |
| DAGRCVCKPAVTGER | 151 | Q13753 | |
| TRLCLPSAGRKDCGQ | 606 | Q86VF2 | |
| RPEFGRRKDAGTCCA | 76 | P19622 | |
| RDCERKAGPCEQAGS | 126 | Q6UY11 | |
| SKFCPAGCRDVAGDI | 171 | Q8N8Z6 | |
| DHGESGPLRCNRCKA | 416 | P53992 | |
| GRSLSKLNLCEDGPC | 26 | Q6ZMJ2 | |
| GRLCSPQCAEVRGFS | 336 | P59044 | |
| DLRGAERCQKGGCVP | 441 | Q9BZF2 | |
| RSTGACNCGRKQAPR | 606 | Q8ND04 | |
| ASDCCVGAAGRRLVK | 21 | Q9BPW5 | |
| GRLSPKTNTCRGCNH | 71 | Q96C24 | |
| IDRLKNCGCLGASPN | 26 | P54136 | |
| NDGPLCKCSAKARRT | 531 | Q9NRR4 | |
| CCDFGRPKEGTSTLQ | 231 | Q9Y5W9 | |
| RSLSGPEQGTACCEL | 86 | Q8IYL2 | |
| PMQGDDVLRCGSRSC | 626 | Q8IYR2 | |
| SSCNGDCGAVRTRKR | 916 | Q9UPZ6 | |
| CGNPTKGLRERRHQC | 331 | Q8IYG6 | |
| RECGGNRRICKAEGS | 451 | Q9H1J1 | |
| FGVDICCRKGSRSPL | 46 | Q9NPF2 | |
| RDDCSLPLSCGSGKE | 911 | Q9H2X0 | |
| RSPARGGDCSRNSCL | 116 | Q96EG3 | |
| RAGTPRCACAGTASE | 81 | P0C880 | |
| GKFLRRNDPECDLCG | 321 | Q96PU4 | |
| DGGRQPRSICTFCLS | 156 | Q12870 | |
| GERPFECLKCGRAFS | 371 | P52740 | |
| RCPDCGKSFGRSTTL | 191 | Q6ZNH5 | |
| RLPCGICGKAFRDAS | 406 | P0CJ78 | |
| GPCSVDRLKGDCSAE | 1216 | Q13129 | |
| CEPGKRDVCVDGSCR | 141 | O95428 | |
| SQRGRCKDGRCVCDP | 316 | P22105 | |
| KATREDRPFRCGQCG | 1291 | O15015 | |
| RGRACNSSAPDLSGC | 306 | Q9Y6F9 | |
| TGTCRDGSAGRLCDK | 811 | Q8WWQ8 | |
| TKCRCGSRIAGPNAL | 16 | Q17RH7 | |
| EGELSTCGCSRAARP | 156 | P41221 | |
| RDRPTICGECGKGFS | 481 | P0CG23 | |
| PGTAGRRCHREKNCE | 306 | O14904 | |
| GRACNKTSRLLDGCG | 331 | O00744 | |
| IGKEGCRPRAFCLAD | 931 | Q8IWB9 | |
| GLSACCRGPLAERQK | 256 | Q8NFA0 | |
| LDGRCEGAKVPSACA | 2231 | Q9Y493 | |
| RVCRACGAGSAELNP | 321 | O14686 |